These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11684364)

  • 1. The role of CYP forms in the metabolism and metabolic activation of HCFCs and other halocarbons.
    White IN; De Matteis F
    Toxicol Lett; 2001 Oct; 124(1-3):121-8. PubMed ID: 11684364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoantigen formation and clastogenic action of HCFC-123 and perchloroethylene in human MCL-5 cells.
    White IN; Razvi N; Gibbs AH; Davies AM; Manno M; Zaccaro C; De Matteis F; Pähler A; Dekant W
    Toxicol Lett; 2001 Oct; 124(1-3):129-38. PubMed ID: 11684365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons.
    Hoet P; Graf ML; Bourdi M; Pohl LR; Duray PH; Chen W; Peter RM; Nelson SD; Verlinden N; Lison D
    Lancet; 1997 Aug; 350(9077):556-9. PubMed ID: 9284778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.
    Urban G; Speerschneider P; Dekant W
    Chem Res Toxicol; 1994; 7(2):170-6. PubMed ID: 8199305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology of chlorofluorocarbon replacements.
    Dekant W
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):75-83. PubMed ID: 8722112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation and toxicity in vitro of HCFC-123 and HCFC-141b: role of cytochrome P450.
    Zanovello A; Ferrara R; Tolando R; Bortolato S; White IN; Manno M
    Toxicol Lett; 2001 Oct; 124(1-3):139-52. PubMed ID: 11684366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation.
    Harris JW; Jones JP; Martin JL; LaRosa AC; Olson MJ; Pohl LR; Anders MW
    Chem Res Toxicol; 1992; 5(5):720-5. PubMed ID: 1446014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane.
    Huwyler J; Aeschlimann D; Christen U; Gut J
    Eur J Biochem; 1992 Jul; 207(1):229-38. PubMed ID: 1628651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inactivation of rat and bovine olfactory cytochrome P450 by three haloethanes.
    Marini S; Longo V; Zaccaro C; De Matteis F; Gervasi PG
    Toxicol Lett; 2001 Oct; 124(1-3):83-90. PubMed ID: 11684360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivation to free radicals and cytotoxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b).
    Zanovello A; Tolando R; Ferrara R; Bortolato S; Manno M
    Xenobiotica; 2001 Feb; 31(2):99-112. PubMed ID: 11407538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
    Dekant W; Assmann M; Urban G
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and toxicity of hydrochlorofluorocarbons: current knowledge and needs for the future.
    Anders MW
    Environ Health Perspect; 1991 Dec; 96():185-91. PubMed ID: 1820265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.
    Harris JW; Pohl LR; Martin JL; Anders MW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1407-10. PubMed ID: 1996342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductive activation of HCFC-123 by methaemalbumin.
    Zanovello A; Ferrara R; Manno M
    Toxicol Lett; 2003 Sep; 144(1):127-36. PubMed ID: 12919730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse Modeling Revealed Reversed Trends in HCFC-141b Emissions for China during 2018-2020.
    Sun Y; Yao B; Hu X; Yang Y; Li B; Ma M; Chi W; Du Q; Hu J; Fang X
    Environ Sci Technol; 2023 Dec; 57(48):19557-19564. PubMed ID: 37978918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)-induced liver toxicity by ethanol in guinea-pigs.
    Hoet P; Buchet JP; Sempoux C; Haufroid V; Rahier J; Lison D
    Arch Toxicol; 2002 Dec; 76(12):707-14. PubMed ID: 12451447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations on the liver toxicity of a blend of HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane) and HCFC-124 (2-chloro-1,1,1,2-tetrafluoroethane) in guinea-pigs.
    Hoet P; Buchet JP; Sempoux C; Nomiyama T; Rahier J; Lison D
    Arch Toxicol; 2001 Jul; 75(5):274-83. PubMed ID: 11548120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats.
    Urban G; Dekant W
    Xenobiotica; 1994 Sep; 24(9):881-92. PubMed ID: 7810170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
    Loizou GD; Anders MW
    Drug Metab Dispos; 1993; 21(4):634-9. PubMed ID: 8104122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.